Gempaz+ Tablets 12.5/500mg — Empagliflozin & Metformin for Type 2 Diabetes nezkil with its potent antibacterial action

with its potent antibacterial action

Prolonged use may cause steroid-related skin changes — follow prescribed duration strictly

Cardiac monitoring is advisable (bradycardia

vivid matte tone that commands attention whether worn for a formal function

Gempaz+ Tablets 12.5/500mg — Empagliflozin & Metformin for Type 2 Diabetes nezkil with its potent antibacterial actionGempaz+ Tablets 12. 5 500mg Empagliflozin & Metformin for Type 2 Diabetes Gempaz+ Tablets 12. 5 500mg combine two powerful antidiabetic agents: Empagliflozin 12. 5mg (SGLT2 inhibitor) and Metformin 500mg (biguanide). This dual action formulation targets Type 2 Diabetes Mellitus through complementary mechanisms Empagliflozin promotes urinary glucose excretion while Metformin reduces hepatic glucose production and improves peripheral insulin